We Need Better Classification and Terminology for “People at High Risk of or in the Process of Developing Lupus”

Development of SLE among “potential SLE” patients seen in consultation: long-term follow-up

(2014) M. Al Daabil et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Assessment of intracellular cytokines and regulatory cells in patients with autoimmune diseases and primary immunodeficiencies — Novel tool for diagnostics and patient follow-up

(2013) Liv T. Osnes et al.   AUTOIMMUNITY REVIEWS

Organ damage in high-risk patients with systemic and incomplete lupus syndromes

(2013) Nancy J. Olsen et al.   RHEUMATOLOGY INTERNATIONAL

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis

(2012) Danielle M Gerlag et al.   ANNALS OF THE RHEUMATIC DISEASES

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

(2012) Michelle Petri et al.   ARTHRITIS AND RHEUMATISM

Undifferentiated CTD: A wide spectrum of autoimmune diseases

(2012) Marta Mosca et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Environmental and Gene-Environment Interactions and Risk of Rheumatoid Arthritis

(2012) Elizabeth W. Karlson et al.   RHEUMATIC DISEASE CLINICS OF NORTH AMERICA

Autoantibody profiling to follow evolution of lupus syndromes

(2012) Nancy J Olsen et al.   ARTHRITIS RESEARCH & THERAPY

Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides

(2010) Latisha D. Heinlen et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromes

(2009) Q.-Z. Li et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Undifferentiated connective tissue disease: a seven-center cross-sectional study of 184 patients

(2009) C. C. Vaz et al.   CLINICAL RHEUMATOLOGY